JOP20190290A1 - جسيم نانوي، عامل تباين للتصوير بالرنين المغناطيسي يحتوي عليه، ومركب ترابطي - Google Patents
جسيم نانوي، عامل تباين للتصوير بالرنين المغناطيسي يحتوي عليه، ومركب ترابطيInfo
- Publication number
- JOP20190290A1 JOP20190290A1 JOP/2019/0290A JOP20190290A JOP20190290A1 JO P20190290 A1 JOP20190290 A1 JO P20190290A1 JO P20190290 A JOP20190290 A JO P20190290A JO P20190290 A1 JOP20190290 A1 JO P20190290A1
- Authority
- JO
- Jordan
- Prior art keywords
- nanoparticle
- magnetic resonance
- contrast agent
- resonance imaging
- ligand compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Abstract
يتعلق الاختراع الحالي بتوفير جسيم نانوي جديد، عامل تباين للتصوير بالرنين المغناطيسي الذي يحتوي عليه، ومركب ترابطي يستخدم لإنتاج الجسيم النانوي. يتعلق الاختراع الحالي بجسيم نانوي يتضمن: جسيم معدني يحتوي على أكسيد حديد؛ ومركب ترابطي مرتبط بذرة معدنية على سطح الجسيم المعدني ويتم تمثيله بالصيغة (3): حيث تكون m عبارة عن عدد صحيح من 1 إلى 4، ويمثل خط متقطع رابطة تناسقية مع ذرة معدنية على سطح الجسيم المعدني.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017126755 | 2017-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20190290A1 true JOP20190290A1 (ar) | 2019-12-19 |
Family
ID=64742350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2019/0290A JOP20190290A1 (ar) | 2017-06-28 | 2018-12-28 | جسيم نانوي، عامل تباين للتصوير بالرنين المغناطيسي يحتوي عليه، ومركب ترابطي |
Country Status (18)
Country | Link |
---|---|
US (1) | US11389550B2 (ar) |
EP (1) | EP3646888A4 (ar) |
JP (1) | JP7107532B2 (ar) |
KR (1) | KR20200018579A (ar) |
CN (1) | CN110799219B (ar) |
AU (1) | AU2018292927B2 (ar) |
BR (1) | BR112019027478A2 (ar) |
CA (1) | CA3068215A1 (ar) |
CO (1) | CO2020000940A2 (ar) |
IL (1) | IL271622A (ar) |
JO (1) | JOP20190290A1 (ar) |
MA (1) | MA49521A (ar) |
PH (1) | PH12019502882A1 (ar) |
RU (1) | RU2767430C2 (ar) |
SG (1) | SG11201912664WA (ar) |
UA (1) | UA125049C2 (ar) |
WO (1) | WO2019004297A1 (ar) |
ZA (1) | ZA202000265B (ar) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113227040A (zh) * | 2018-12-27 | 2021-08-06 | 安斯泰来制药株式会社 | 纳米颗粒、包含该纳米颗粒的核磁共振成像造影剂及两性离子配体化合物 |
JOP20210167A1 (ar) | 2018-12-27 | 2023-01-30 | Astellas Pharma Inc | طريقة لإنتاج جسيم نانوي يشتمل على جسيم معدني يحتوي على أكسيد حديد يرتبط به واحد أو أكثر من المركبات الترابطية الآلفة للماء تناسقيًا |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123542A (en) | 1960-10-13 | 1964-03-03 | Electrolytic marking medium | |
US8574549B2 (en) | 2008-12-29 | 2013-11-05 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
US8728440B2 (en) | 2012-08-23 | 2014-05-20 | General Electric Company | Nanoparticulate compositions for diagnostic imaging |
US9399075B2 (en) | 2008-12-29 | 2016-07-26 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
US20100166664A1 (en) | 2008-12-29 | 2010-07-01 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
US8728529B2 (en) | 2008-12-29 | 2014-05-20 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
ES2647567T3 (es) * | 2008-12-29 | 2017-12-22 | General Electric Company | Agentes de contraste de nanopartículas para el diagnóstico por imágenes |
US9205155B2 (en) * | 2009-10-30 | 2015-12-08 | General Electric Company | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
KR20130045647A (ko) * | 2011-10-26 | 2013-05-06 | 한국기초과학지원연구원 | 양쪽성 이온으로 코팅된 자기공명영상 조영제 |
WO2013090601A2 (en) * | 2011-12-16 | 2013-06-20 | Massachusetts Institute Of Technology | Compact nanoparticles for biological applications |
US8821838B2 (en) | 2012-08-23 | 2014-09-02 | General Electric Company | Nanoparticulate compositions for diagnostic imaging |
CN104740654B (zh) * | 2013-12-30 | 2017-12-29 | 中国科学院化学研究所 | 磁性纳米颗粒磁共振造影剂和增强磁性纳米颗粒弛豫率的方法 |
WO2015104664A1 (en) * | 2014-01-07 | 2015-07-16 | Colorobbia Italia S.P.A. | Magnetic nanoparticles functionalized with cathecol, production and use thereof |
CA2961358C (en) * | 2014-09-15 | 2023-08-01 | Massachusetts Institute Of Technology | Nanoparticles for magnetic resonance imaging applications |
JP6577250B2 (ja) * | 2015-06-02 | 2019-09-18 | 国立大学法人 東京大学 | 複合半透膜 |
CN106390146A (zh) * | 2015-08-03 | 2017-02-15 | 天津大学 | 聚磺酸甜菜碱两性电解质修饰的磁性纳米粒子及其制备方法和应用 |
-
2018
- 2018-06-27 RU RU2019143780A patent/RU2767430C2/ru active
- 2018-06-27 WO PCT/JP2018/024416 patent/WO2019004297A1/ja unknown
- 2018-06-27 JP JP2019526990A patent/JP7107532B2/ja active Active
- 2018-06-27 CA CA3068215A patent/CA3068215A1/en active Pending
- 2018-06-27 MA MA049521A patent/MA49521A/fr unknown
- 2018-06-27 US US16/624,946 patent/US11389550B2/en active Active
- 2018-06-27 KR KR1020207000498A patent/KR20200018579A/ko not_active Application Discontinuation
- 2018-06-27 CN CN201880041378.2A patent/CN110799219B/zh active Active
- 2018-06-27 BR BR112019027478-2A patent/BR112019027478A2/pt unknown
- 2018-06-27 UA UAA202000282A patent/UA125049C2/uk unknown
- 2018-06-27 EP EP18823223.5A patent/EP3646888A4/en not_active Withdrawn
- 2018-06-27 AU AU2018292927A patent/AU2018292927B2/en active Active
- 2018-06-27 SG SG11201912664WA patent/SG11201912664WA/en unknown
- 2018-12-28 JO JOP/2019/0290A patent/JOP20190290A1/ar unknown
-
2019
- 2019-12-19 IL IL271622A patent/IL271622A/en unknown
- 2019-12-19 PH PH12019502882A patent/PH12019502882A1/en unknown
-
2020
- 2020-01-15 ZA ZA2020/00265A patent/ZA202000265B/en unknown
- 2020-01-27 CO CONC2020/0000940A patent/CO2020000940A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
RU2019143780A3 (ar) | 2021-08-27 |
US20200330617A1 (en) | 2020-10-22 |
CN110799219A (zh) | 2020-02-14 |
RU2019143780A (ru) | 2021-06-25 |
CN110799219B (zh) | 2023-01-06 |
IL271622A (en) | 2020-02-27 |
CO2020000940A2 (es) | 2020-02-18 |
PH12019502882A1 (en) | 2020-10-26 |
AU2018292927A1 (en) | 2020-02-06 |
RU2767430C2 (ru) | 2022-03-17 |
ZA202000265B (en) | 2021-07-28 |
CA3068215A1 (en) | 2019-01-03 |
UA125049C2 (uk) | 2021-12-29 |
US11389550B2 (en) | 2022-07-19 |
MA49521A (fr) | 2020-05-06 |
WO2019004297A1 (ja) | 2019-01-03 |
JPWO2019004297A1 (ja) | 2020-04-30 |
SG11201912664WA (en) | 2020-01-30 |
BR112019027478A2 (pt) | 2020-07-07 |
KR20200018579A (ko) | 2020-02-19 |
AU2018292927B2 (en) | 2021-11-25 |
EP3646888A4 (en) | 2021-04-14 |
JP7107532B2 (ja) | 2022-07-27 |
EP3646888A1 (en) | 2020-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201114133D0 (en) | Coelenterazine analogs and manufacturing method thereof | |
JOP20190290A1 (ar) | جسيم نانوي، عامل تباين للتصوير بالرنين المغناطيسي يحتوي عليه، ومركب ترابطي | |
PH12017502205A1 (en) | New gadolinium chelate compounds for use in magnetic resonance imaging | |
MY180083A (en) | Tetrahydropyrrolothiazine compounds | |
MX2022014611A (es) | Compuestos para tomografia por emision de positrones. | |
MY181989A (en) | Process for making mixtures of chelating agents | |
MX2013004526A (es) | Derivados de heteroarilpiperidina y -piperazina como fungicidas. | |
EP2570776A3 (en) | Inductive Detection Encoder and Digital Micrometer | |
MX2022010230A (es) | Complejos de anillos macrociclicos de pentaaza que poseen biodisponibilidad oral. | |
PH12015501633A1 (en) | Pest-control composition and pest-control method | |
MX2018007739A (es) | Ligandos macrociclicos con uno o varios grupos picolinato, sus complejos así como sus utilizaciones medicas. | |
BR112017004214A2 (pt) | processo para a preparação de pigmentos de hematita, e processo para a preparação de pigmentos vermelhos de óxido de ferro | |
IN2015DN00665A (ar) | ||
PH12019501147A1 (en) | Metallic ore pellets | |
JOP20210167A1 (ar) | طريقة لإنتاج جسيم نانوي يشتمل على جسيم معدني يحتوي على أكسيد حديد يرتبط به واحد أو أكثر من المركبات الترابطية الآلفة للماء تناسقيًا | |
IN2015DN02877A (ar) | ||
AU2017239848B2 (en) | Novel compound and synthesis method therefor | |
MX2017003290A (es) | Proceso para la preparacion de derivados de trifenilbuteno. | |
MX2021005999A (es) | Composiciones de quelatos metalicos o complejos metalicos que comprenden nanoparticulas minimas. | |
TW201612135A (en) | Compound metal oxide fine particles and method of producing the same | |
MX2019014352A (es) | Compuesto de oxadiazolina y formulacion para controlar organismos perjudiciales. | |
MY180415A (en) | Crystal of alkali metal n-acetylneuraminate anhydrate, and process for producing same | |
MX2021001382A (es) | Un metodo para la preparacion de nitrilos de fluoroalquilo y su uso para preparar tetrazoles fluoroalquilo relacionados. | |
PL417163A1 (pl) | Sposób wytwarzania prekursora katalizatora żelazowego do syntezy amoniaku | |
EP4045095C0 (de) | Eisen(iii)-komplexe mit neuen kontrastmitteleigenschaften für die magnetresonanztomographie |